Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 28 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Marciniak TA, Cherepanov V, Golukhova I, Hyun Kim M, Serebruany V. Drug discontinuation and follow-up rates in oral antithrombotic trials. JAMA Intern Med 2016;176:11 de enero. [Ref.ID 99961]
2.Enlace a cita original Cita con resumen
Montalescot G, Sabatine MS. Oral dual antiplatelet therapy: what have we learnt from recent trials?. Eur Heart J 2015:6 de agosto. [Ref.ID 99343]
3.Tiene citas relacionadas Cita con resumen
Gagne JJ, Bykov K, Choudhry NK, Toomey TJ, Connolly JG, Avorn J. Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ 2013;347:11. [Ref.ID 96346]
4.Tiene citas relacionadas Cita con resumen
Hirschl MM. Smoking status and the effects of antiplatelet drugs. BMJ 2013;347:10. [Ref.ID 96345]
5.Tiene citas relacionadas
Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran DJ, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzylio W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet 2013;382:605-13. [Ref.ID 96025]
6.Tiene citas relacionadas
Swaminathan RV, Feldman DN. TRILOGY ACS: prasugrel of benefit only after angiography?. Lancet 2013;382:580-2. [Ref.ID 96024]
7. Cita con resumen
Gurbel PA, Nolin TD, Tantry US. Clopidogrel efficacy and cigarette smoking status. JAMA 2012;307:2495-6. [Ref.ID 93316]
8.Enlace a cita original
Passacquale G, Ferro A. Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events. BMJ 2011;342:1415-20. [Ref.ID 90956]
9.Tiene citas relacionadas
Cattaneo M. Prasugrel and cancer. Arch Intern Med 2010;170:1944. [Ref.ID 89705]
10.Tiene citas relacionadas
Goldstein MR, Mascitelli L, Pezzetta F. Platelet inhibition and cancer promotion. Arch Intern Med 2010;170:1943-4. [Ref.ID 89704]
11.
Sica DA. Angiotensin receptor blockers and the risk of malignancy: a note of caution. Drug Saf 2010;33:709-12. [Ref.ID 89266]
12.Tiene citas relacionadas Cita con resumen
Floyd JS, Serebruany VL. Prasugrel as a potential cancer promoter: review of the unpublished data. Arch Intern Med 2010;170:1078-80. [Ref.ID 88851]
13.Tiene citas relacionadas Cita con resumen
Chua D, Ignaszewski A. Clopidogrel in acute coronary syndromes. BMJ 2009;338:998-1002. [Ref.ID 85705]
14.Tiene citas relacionadas
Kent DM, Thaler DE. Stroke prevention - Insight from incoherence. N Engl J Med 2008;359:1287-9. [Ref.ID 83987]
15.Tiene citas relacionadas Cita con resumen
Sacco RL, Diener HC, Yusuf S, Cotton D, Ôunpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BPL, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Maelen CV, Voigt T, Weber M, Yoon BW, for the PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238-51. [Ref.ID 83983]
16. Cita con resumen
Yusuf S, Diener HC, Sacco RL, Cotton D, Ôunpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BPL, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW, for the PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008;359:1225-37. [Ref.ID 83982]
18.
Eshaghian S, Amin S, Shah PK, Diamond GA. Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med 2007;146:434-41. [Ref.ID 79711]
19. Cita con resumen
Agustí A, Bosch M. Prevención de la enfermedad aterotrombótica con la combinación de dos antiagregantes plaquetarios. Med Clin (Barc) 2006;127:153-5. [Ref.ID 77515]
Seleccionar todas
 
 1 a 20 de 28 siguiente >>